AngioDynamics, Inc. (NASDAQ:ANGO) medical instruments manufacturer and supplier will be discussing 1Q21 financial results with the investment community.on 29th September 2020 at 8:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.angiodynamics.com
Earnings Expectation
AngioDynamics, Inc. medical instruments manufacturer and supplier, is expected to report first quarter earnings results, before market open, on Tuesday 29th September 2020. Analysts polled by Thomson Reuters anticipate first quarter loss of $ 0.07 per share from revenue of $ 65.10 million. Looking ahead, the full year loss are expected at $ 0.1 per share on the revenues of $ 274.48 million.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.
